Serum amyloid A-positive hepatocellular neoplasms in the resected livers from 3 patients with alcoholic cirrhosis

Histology and Histopathology

Volumn 28, Issue 11, 2013, Pages 1499-1505

  Sasaki, Motoko ^a   Kondo, Fukuo ^b   Sawai, Yoshiyuki ^c   Imai, Yasuharu ^c   Kadowaki, Susumu ^b   Sano, Keiji ^b   Fukusato, Toshio ^b   Matsui, Osamu ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c Ikeda Municipal Hospital   (Japan)

Author keywords

Alcoholic cirrhosis; Focal nodular hyperplasia; Inflammatory hepatocellular adenoma; Serum amyloid A positive hepatocellular neoplasm

Indexed keywords

SERUM AMYLOID A;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; SERUM AMYLOID A PROTEIN;

EID: 84886292505     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bioulac-Sage P., Rebouissou S., Thomas C., Blanc J. F., Saric J., Sa Cunha A., Rullier A., Cubel G., Couchy G., Imbeaud S., Balabaud C. and Zucman-Rossi J. (2007). Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46, 740-748.
2. Bioulac-Sage P., Laumonier H., Couchy G., Le Bail B., Sa Cunha A., Rullier A., Laurent C., Blanc J. F., Cubel G., Trillaud H., Zucman-Rossi J., Balabaud C. and Saric J. (2009). Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50, 481-489.
3. Bioulac-Sage P., Balabaud C. and Wanless I. (2010). Focal nodular hyperplasia and hepatocellular adenoma. In: WHO classification of tumours of the digestive system. 4th ed. Bosman F., Carneiro F., Hruban H. and Theise N. (eds). Lyon. IARC. pp 198-204.
4. Di Tommaso L., Destro A., Seok J.Y., Balladore E., Terracciano L., Sangiovanni A., Iavarone M., Colombo M., Jang J.J., Yu E., Jin S. Y., Morenghi E., Park Y.N. and Roncalli M. (2009). The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J. Hepatol. 50, 746-754.
5. Farges O., Ferreira N., Dokmak S., Belghiti J., Bedossa P. and Paradis V. (2011). Changing trends in malignant transformation of hepatocellular adenoma. Gut 60, 85-89.
6. Kitao A., Zen Y., Matsui O., Gabata T., Kobayashi S., Koda W., Kozaka K., Yoneda N., Yamashita T., Kaneko S. and Nakanuma Y. (2011). Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging-correlation with molecular transporters and histopathologic features. Radiology 256, 817-826.
7. Kobayashi S., Matsui O., Kamura T., Yamamoto S., Yoneda N., Gabata T., Terayama N. and Sanada J. (2007). Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma. J. Comput. Assist. Tomogr. 31, 557-563.
8. Nakashima O., Kurogi M., Yamaguchi R., Miyaaki H., Fujimoto M., Yano H., Kumabe T., Hayabuchi N., Hisatomi J., Sata M. and Kojiro M. (2004). Unique hypervascular nodules in alcoholic liver cirrhosis: identical to focal nodular hyperplasia-like nodules? J. Hepatol. 41, 992-998.
9. Rebouissou S., Bioulac-Sage P. and Zucman-Rossi J. (2008). Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J. Hepatol. 48, 163-170.
10. Sasaki M., Ikeda H., Sato Y. and Nakanuma Y. (2006). Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis. Am. J. Pathol. 169, 831-845.
11. Sasaki M., Yoneda N., Kitamura S., Sato Y. and Nakanuma Y. (2011). Characterization of hepatocellular adenoma based on the phenotypic classification: the Kanazawa experience. Hepatol. Res. 41, 982-988.
12. Sasaki M., Yoneda N., Kitamura S., Sato Y. and Nakanuma Y. (2012). A serum amyloid A-positive hepatocellular neoplasm arising in alcoholic cirrhosis: a previously unrecognized type of inflammatory hepatocellular tumor. Mod. Pathol. 25, 1584-1593.
13. Sekine S., Ogawa R., Ojima H. and Kanai Y. (2011). Expression of SLCO1B3 is associated with intratumoral cholestasis and CTNNB1 mutations in hepatocellular carcinoma. Cancer Sci. 102, 1742-1747.
14. Terada T., Kitani S., Ueda K., Nakanuma Y., Kitagawa K. and Masuda S. (1993). Adenomatous hyperplasia of the liver resembling focal nodular hyperplasia in patients with chronic liver disease. Virchows Arch. (A) 422, 247-252.
15. Zucman-Rossi J., Jeannot E., Nhieu J. T., Scoazec J. Y., Guettier C., Rebouissou S., Bacq Y., Leteurtre E., Paradis V., Michalak S., Wendum D., Chiche L., Fabre M., Mellottee L., Laurent C., Partensky C., Castaing D., Zafrani E. S., Laurent-Puig P., Balabaud C. and Bioulac-Sage P. (2006). Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43, 515-524.